Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
allogeneic human mesenchymal stem cells (Longeveron, 912b28)
- Development stage
- Unknown
- Lead developer
- Longeveron
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
Allogeneic human mesenchymal stem cells (Allo-hMSCs) are an investigational cell therapy being developed by the University of Miami for the treatment of acute ischemic stroke. Administered via intravenous infusion, these donor-derived multipotent stromal cells are designed to migrate to the site of brain injury and promote recovery through multiple mechanisms, including the secretion of neurotrophic paracrine factors, immunomodulation of the inflammatory response, and stimulation of endogenous neural repair processes. The therapy is currently being evaluated in the EXPAND expanded access study, following earlier research by the University of Miami demonstrating safety and potential efficacy in chronic stroke patients.
- Other names
- Allo-hMSCsallogeneic human mesenchymal stem cells (University of Miami)
Beyond the preview
Go deeper on allogeneic human mesenchymal stem cells (Longeveron, 912b28).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on allogeneic human mesenchymal stem cells (Longeveron, 912b28).